TeneoBio Competitors and Similar CompaniesClear all
TeneoBio's competitors and similar companies include Aptevo Therapeutics, Enara Bio, Rain Therapeutics and CellPly.
 TeneoBio TeneoBio is a biotechnology company developing biologics such as human heavy chain antibodies (UniAbs) as therapeutics against cancer, autoimmunity, and infectious diseases. |  Aptevo Therapeutics Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. |  Enara Bio Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer. |  Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. |  CellPly CellPly is a company developing in-vitro diagnostic platforms supporting personalized cancer treatment. | |
Founding Date | Founding Date 2009 | Founding Date 2016 | Founding Date 2016 | Founding Date 2017 | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Private |
Tags | |||||
Locations | Locations Newark, US HQ | Locations Seattle, US HQ | Locations Oxford, GB HQ London, GB London, GB Oxford, GB | Locations Newark, US HQ | Locations Bologna, IT HQ Bologna, IT |
Employees | Employees 20 | Employees 1182% decrease | Employees 622% increase | Employees 6343% increase | Employees 313% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.1 m | Valuation ($) N/A | Valuation ($) 44 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($26m) (FY, 2025) | Net income N/A | Net income ($75.7m) (FY, 2022) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 17.5m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 341.6k (over 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 17.5m | Total funding raised $ 82.4m | Total funding raised $ 5.9m |
For sources of this data, please see the company profile
View Company Profiles
Aptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
View companyEnara Bio
HQ
Oxford, GB
Employees
62↑ 2% increase
Enara Bio (formerly known as Ervaxx) is a biotech company specializing in the use of Dark Antigens to deliver vaccines and other immunotherapies for treating and preventing cancer.
View companyRain Therapeutics
HQ
Newark, US
Employees
63↑ 43% increase
Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients.
View companyCellPly
HQ
Bologna, IT
Employees
31↓ 3% decrease
CellPly is a company developing in-vitro diagnostic platforms supporting personalized cancer treatment.
View company